Free tool
Stocks listed on Nasdaq CM
We cover 137 companies listed on Nasdaq CM. The median market value in the group is $353.03M. Across the group, the median move over the past trading day is −0.09%. 63% of the 136 with a 200-day average trade above it. Price change over the past year runs from −52.3% to +224.3% across the middle 80 percent of the group, with a median of +34.6%.
Other lists in this group
Table
137 of 1,344 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| TGTX | TG Therapeutics, Inc. Common Stock | $55.03 | +0.29% | +87.94% | +92.61% |
| BLTE | Belite Bio, Inc | $156.69 | +0.47% | −1.62% | +144.07% |
| LQDA | Liquidia Corporation | $71.36 | −17.81% | +127.26% | +154.86% |
| DNTH | Dianthus Therapeutics, Inc. | $110.76 | +9.01% | +179.13% | +356.93% |
| CELC | Celcuity Inc. | $95.08 | +15.30% | −5.44% | +90.31% |
| VKTX | Viking Therapeutics, Inc. | $34.38 | +1.54% | −2.94% | +29.15% |
| PLSE | Pulse Biosciences, Inc. | $48.10 | +35.61% | +259.22% | +203.47% |
| IMNM | Immunome, Inc. | $28.75 | +23.82% | +38.09% | +188.94% |
| CLDX | Celldex Therapeutics, Inc. | $40.57 | +14.02% | +50.20% | +79.51% |
| SLS | SELLAS Life Sciences Group, Inc. | $13.73 | +36.08% | +215.63% | +615.10% |
| VRDN | Viridian Therapeutics, Inc. | $24.26 | +24.35% | −20.93% | +30.71% |
| RGC | Regencell Bioscience Holdings Limited | $5.50 | −7.87% | −73.22% | −61.38% |
| AXGN | AxoGen, Inc. Common Stock | $51.58 | +25.35% | +66.39% | +219.58% |
| NKTR | Nektar Therapeutics | $73.77 | +4.24% | +69.90% | +151.95% |
| UFPT | UFP Technologies, Inc. | $304.57 | +18.02% | +36.33% | +41.94% |
| NEO | NeoGenomics, Inc. | $17.37 | +29.63% | +47.70% | +145.34% |
| ESTA | Establishment Labs Holdings Inc. | $72.45 | −21.16% | +5.24% | +70.71% |
| PIII | P3 Health Partners Inc. | $9.92 | −5.70% | +183.43% | +26.37% |
| ASTH | Astrana Health, Inc. | $38.61 | +1.69% | +53.09% | +23.71% |
| DMRA | Damora Therapeutics, Inc. | $30.39 | +3.30% | +39.28% | +804.46% |
| BLFS | BioLife Solutions, Inc. | $37.00 | +15.70% | +54.88% | +45.50% |
| FBRX | Forte Biosciences, Inc. | $76.99 | +0.44% | +226.09% | +589.87% |
| IMTX | Immatics N.V. | $9.43 | +7.96% | −9.76% | +74.63% |
| JBIO | Jade Biosciences, Inc. | $21.33 | +8.27% | +50.64% | +168.30% |
| DRTS | Alpha Tau Medical Ltd. | $14.96 | +29.52% | +209.73% | +343.92% |
| NUTX | Nutex Health Inc. | $195.92 | +31.46% | +32.21% | +118.22% |
| MLTX | MoonLake Immunotherapeutics | $15.62 | −16.52% | +30.71% | −71.82% |
| ODTX | Odyssey Therapeutics, Inc. | $25.62 | +39.01% | +56.03% | +56.03% |
| AVTX | Avalo Therapeutics, Inc. | $20.55 | +5.28% | +20.74% | +112.95% |
| LXRX | Lexicon Pharmaceuticals, Inc. | $2.31 | −1.28% | +102.63% | +104.42% |
| IMMX | Immix Biopharma, Inc. | $14.07 | +66.71% | +159.12% | +617.86% |
| DBVT | DBV Technologies S.A. | $14.52 | +7.56% | −23.78% | +53.00% |
| TALK | Talkspace, Inc. | $5.25 | +0.77% | +49.57% | +93.73% |
| ACHV | Achieve Life Sciences, Inc. | $8.27 | +33.82% | +66.40% | +177.52% |
| AHG | Akso Health Group | $0.99 | −32.19% | −38.12% | −43.10% |
| NVCT | Nuvectis Pharma, Inc. | $25.00 | +26.14% | +193.77% | +275.94% |
| AHCO | AdaptHealth Corp. | $5.67 | −49.47% | −41.37% | −38.44% |
| MNPR | Monopar Therapeutics Inc. | $113.72 | +4.24% | +72.28% | +226.69% |
| DRUG | Bright Minds Biosciences Inc. | $76.63 | +6.49% | −8.18% | +76.73% |
| SSII | SS Innovations International, Inc. | $3.57 | −9.16% | −36.81% | −50.55% |
| GYRE | Gyre Therapeutics, Inc. | $6.65 | +11.02% | −2.35% | −18.00% |
| PROK | ProKidney Corp. | $1.74 | +12.99% | −21.97% | −30.12% |
| CBIO | Crescent Biopharma, Inc. | $18.02 | +9.61% | +62.64% | +26.46% |
| MDXG | MiMedx Group, Inc. | $4.42 | +1.38% | −31.79% | −38.35% |
| VSTM | Verastem, Inc. | $7.39 | +18.62% | +2.21% | −20.45% |
| ZURA | Zura Bio Limited | $5.99 | +8.12% | +7.93% | +177.31% |
| DCTH | Delcath Systems, Inc. | $16.40 | +41.99% | +64.82% | +49.91% |
| OVID | Ovid Therapeutics Inc. | $2.88 | +22.03% | +63.64% | +128.57% |
| ENTX | Entera Bio Ltd. | $3.19 | −2.15% | +80.23% | +62.76% |
| SRTA | Strata Critical Medical, Inc. | $6.12 | +20.24% | +24.14% | +33.62% |
| TOI | Starling Oncology Inc | $6.20 | +25.25% | +68.94% | +79.19% |
| CLPT | ClearPoint Neuro, Inc. | $16.37 | +12.66% | +16.68% | +53.85% |
| EPRX | Eupraxia Pharmaceuticals Inc. | $7.43 | +21.80% | −1.85% | +40.72% |
| RLMD | Relmada Therapeutics, Inc. | $4.55 | −13.00% | +4.12% | +579.10% |
| RZLT | Rezolute, Inc. | $5.04 | +2.44% | +132.79% | −30.00% |
| QTTB | Q32 Bio Inc. | $16.18 | +2.99% | +370.35% | +840.70% |
| OCGN | Ocugen, Inc. | $1.41 | +13.71% | +2.17% | +35.58% |
| MCTA | Charming Medical Limited | $29.36 | 0.00% | 0.00% | +319.36% |
| BNTC | Benitec Biopharma Inc. | $12.88 | +8.33% | +2.34% | +0.16% |
| CMPX | Compass Therapeutics, Inc. | $2.43 | +19.12% | −53.00% | −25.91% |
| FENC | Fennec Pharmaceuticals Inc. | $12.17 | +22.43% | +58.46% | +34.62% |
| GALT | Galectin Therapeutics Inc. | $4.15 | +22.42% | +2.47% | +4.27% |
| XFOR | X4 Pharmaceuticals, Inc. | $4.17 | +6.11% | +7.20% | −1.42% |
| IPSC | Century Therapeutics, Inc. | $2.14 | +4.39% | +115.08% | +315.53% |
| AGEN | Agenus Inc. | $8.25 | +25.00% | +155.42% | +81.72% |
| PALI | Palisade Bio, Inc. | $2.13 | +5.45% | −14.80% | +222.73% |
| DMAC | DiaMedica Therapeutics Inc. | $6.70 | +0.90% | −15.51% | +12.04% |
| VMD | Viemed Healthcare, Inc. | $9.33 | −21.73% | +29.22% | +29.94% |
| SABS | SAB Biotherapeutics, Inc. | $3.88 | +12.46% | +2.92% | +83.02% |
| IKT | Inhibikase Therapeutics, Inc. | $2.49 | +7.79% | +27.69% | +39.11% |
| ABEO | Abeona Therapeutics Inc. | $6.01 | −0.17% | +13.18% | −12.90% |
| PRQR | ProQR Therapeutics N.V. | $2.35 | +33.52% | +18.09% | +6.33% |
| RCEL | AVITA Medical, Inc. | $10.59 | +129.72% | +205.19% | +133.77% |
| SMTI | Sanara MedTech Inc. | $34.65 | +30.07% | +50.00% | +2.09% |
| IRD | Opus Genetics, Inc. | $3.80 | +11.44% | +79.25% | +216.67% |
| AMRN | Amarin Corporation plc | $14.38 | +3.05% | +4.77% | −7.08% |
| CV | CapsoVision, Inc. | $5.82 | −12.08% | −43.16% | +46.97% |
| WHWK | Whitehawk Therapeutics, Inc. | $4.84 | +31.52% | +98.36% | +167.40% |
| SRZN | Surrozen, Inc. | $23.71 | +22.22% | +10.02% | +107.98% |
| ELDN | Eledon Pharmaceuticals, Inc. | $3.35 | −1.47% | +106.79% | +29.84% |
| CGEN | Compugen Ltd. | $2.84 | +25.66% | +83.23% | +93.20% |
| GLSI | Greenwich LifeSciences, Inc. | $18.23 | +35.54% | −6.37% | +56.21% |
| NAGE | Niagen Bioscience, Inc. | $3.30 | +0.30% | −47.20% | −66.22% |
| SLGL | Sol-Gel Technologies Ltd. | $79.43 | −4.38% | +88.45% | +261.87% |
| PROF | Profound Medical Corp. | $7.11 | −1.93% | −7.18% | +57.30% |
| NERV | Minerva Neurosciences, Inc. | $5.43 | +26.87% | +38.52% | +129.11% |
| ACB | Aurora Cannabis Inc. | $4.00 | +47.06% | −7.83% | −24.95% |
| AKBA | Akebia Therapeutics, Inc. | $0.91 | −28.62% | −41.52% | −69.88% |
| CRDL | Cardiol Therapeutics Inc. | $2.14 | +78.33% | +115.29% | +91.07% |
| SY | So-Young International Inc. | $2.40 | +22.45% | −10.11% | −38.93% |
| DTIL | Precision BioSciences, Inc. | $8.49 | +18.41% | +107.07% | +69.46% |
| ORGO | Organogenesis Holdings Inc. | $1.75 | −30.83% | −62.24% | −63.84% |
| IMUX | Immunic, Inc. | $16.49 | +23.61% | +182.85% | +92.87% |
| NGEN | NervGen Pharma Corp. | $2.21 | +37.27% | −62.41% | −8.30% |
| HITI | High Tide Inc. | $2.52 | +22.33% | −10.00% | −30.00% |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | $11.30 | +24.38% | +43.58% | +7.93% |
| ORMP | Oramed Pharmaceuticals Inc. | $5.34 | +28.06% | +96.84% | +159.19% |
| DERM | Journey Medical Corporation | $7.55 | +19.57% | +1.28% | +0.87% |
| CUE | Cue Biopharma, Inc. | $28.85 | −4.63% | +185.36% | +16.42% |
| ZJYL | Jin Medical International Ltd. | $2.79 | +45.31% | −38.00% | −82.97% |
| ACOG | Alpha Cognition Inc. | $9.41 | +11.89% | +44.77% | +14.20% |
| PDEX | Pro-Dex, Inc. | $63.84 | +13.31% | +69.25% | +40.31% |
| KRRO | Korro Bio, Inc. | $13.68 | +30.29% | +69.94% | −36.61% |
| LUCD | Lucid Diagnostics Inc. | $0.97 | +6.20% | −13.33% | −22.96% |
| CNTN | Canton Strategic Holdings, Inc. | $2.23 | +9.31% | −34.02% | −55.04% |
| SPRB | Spruce Biosciences, Inc. | $61.48 | +47.79% | −32.22% | +721.93% |
| KZIA | Kazia Therapeutics Limited | $14.60 | +15.05% | +192.00% | +86.94% |
| TNYA | Tenaya Therapeutics, Inc. | $0.70 | −7.91% | −5.28% | −36.71% |
| SPRC | SciSparc Ltd. | $6.74 | +26.45% | −46.51% | −82.42% |
| OTLK | Outlook Therapeutics, Inc. | $0.62 | −31.05% | −5.56% | −73.76% |
| NRXP | NRx Pharmaceuticals, Inc. | $3.46 | −2.26% | +32.06% | +34.11% |
| EQ | Equillium, Inc. | $2.36 | +1.72% | +54.25% | +23.56% |
| UNCY | Unicycive Therapeutics, Inc. | $5.43 | +9.92% | −6.38% | +27.17% |
| KRMD | KORU Medical Systems, Inc. | $3.21 | −19.95% | −42.78% | −24.47% |
| OPRX | OptimizeRx Corporation | $7.75 | +22.24% | −37.60% | −55.79% |
| INDP | Indaptus Therapeutics, Inc. | $1.14 | −34.10% | −58.39% | −82.19% |
| IMDX | Insight Molecular Diagnostics Inc. | $4.30 | −6.72% | −39.94% | +73.39% |
| EMPG | Empro Group Inc | $17.36 | 0.00% | 0.00% | +76.60% |
| TLSA | Tiziana Life Sciences Ltd | $1.09 | +12.37% | −31.87% | −41.08% |
| HURA | TuHURA Biosciences, Inc. | $2.13 | 0.00% | +184.00% | −26.55% |
| INO | Inovio Pharmaceuticals, Inc. | $1.30 | +26.21% | −23.08% | −47.15% |
| VTVT | vTv Therapeutics Inc. | $33.57 | +8.01% | −15.23% | +106.71% |
| ENGN | enGene Therapeutics Inc. | $1.95 | +10.80% | −77.97% | −55.07% |
| PMN | ProMIS Neurosciences, Inc. | $14.46 | −0.41% | +102.52% | +9.13% |
| CBUS | Cibus, Inc. | $1.68 | −13.40% | −10.64% | +27.27% |
| VANI | Vivani Medical, Inc. | $1.42 | +8.02% | +11.42% | +15.98% |
| GNLX | Genelux Corporation | $2.73 | −6.51% | −40.00% | −25.00% |
| ANIX | Anixa Biosciences, Inc. | $3.61 | +2.41% | +14.08% | +22.20% |
| JYNT | The Joint Corp. | $8.54 | −1.04% | −3.50% | −20.19% |
| QUCY | Quantum Cyber N.V. | $1.38 | +26.15% | +18.53% | −15.12% |
| COYA | Coya Therapeutics, Inc. | $4.87 | +21.75% | −13.81% | −25.76% |
| NAUT | Nautilus Biotechnology, Inc. | $0.94 | −21.88% | −50.92% | +33.34% |
| ONCY | Oncolytics Biotech Inc. | $0.86 | +8.30% | −12.69% | −19.28% |
| LNSR | LENSAR, Inc. | $8.65 | +61.68% | −25.50% | −29.04% |
| BGM | BGM Group Ltd. | $0.27 | −3.58% | −92.32% | −96.61% |
| PYPD | PolyPid Ltd. | $5.11 | +36.27% | +17.47% | +49.42% |
| MBOT | Microbot Medical Inc. | $1.52 | −9.52% | −27.96% | −62.65% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.